Logo Lanfrica

Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis

Domaine:

healthcare

Type de record:

paper
Créateur:
MahSeaJamKee
Éditeur:
Ame
Hôte:
Linezolid is widely used for drug-resistant tuberculosis (DR-TB) but has a narrow therapeutic index. To inform dose optimization, we aimed to characterize the population pharmacokinetics of linezolid in South African participants with DR-TB and explore the effect of covariates, including HIV coinfection, on drug exposure.

Licenses

https://doi.org/10.1128/ASMCopyrightv2https://journals.asm.org/non-commercial-tdm-license

Similaires

Ethionamide population pharmacokinetics/pharmacodynamics and therapeutic implications in South African adult patients with drug‐resistant tuberculosis

Introduction Ethionamide is part of the drug‐resistant tuberculosis regimen whose pharmacokinetic (

Early Safety and Efficacy of Linezolid-Based Combination Therapy among Patients with Drug-Resistant Tuberculosis in North-Western Nigeria

Background: The emergence of drug-resistant tuberculosis (DRTB) has continued to pose a threat to p

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The pharmacokinetic properties of isoniazid are well c

Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV

Tuberculosis is an important cause of maternal morbidity, but little is known about the effects of p

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

Objectives Patients with highly resistant tuberculosis have few treatment option

Emergence of Dual Bedaquiline and Linezolid Resistance During Treatment of Pre-Extensively Drug-Resistant Tuberculosis: A Case Report from Zambia